DK Life Science Co., Ltd. (KOSDAQ:303810)

DK Life Science Revenue

DK Life Science had revenue of 33.08B KRW in the quarter ending March 31, 2026, a decrease of -5.61%. This brings the company's revenue in the last twelve months to 128.38B, down -3.69% year-over-year. In the year 2025, DK Life Science had annual revenue of 130.34B, down -1.12%.

• Revenue (ttm): 128.38B
• Revenue Growth: -3.69%
• P/S Ratio: 0.67
• Revenue / Employee: 1.28B
• Employees: 100
• Market Cap: 86.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	130.34B	-1.47B	-1.12%
Dec 31, 2024	131.82B	11.65B	9.70%
Dec 31, 2023	120.16B	12.93B	12.05%
Dec 31, 2022	107.23B	4.57B	4.45%
Dec 31, 2021	102.67B	-6.91B	-6.31%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error